Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome.
Vuaroqueaux V, Urban P, Labuhn M, Delorenzi M, Wirapati P, Benz CC, Flury R, Dieterich H, Spyratos F, Eppenberger U, Eppenberger-Castori S.
Vuaroqueaux V, et al. Among authors: eppenberger u.
Breast Cancer Res. 2007;9(3):R33. doi: 10.1186/bcr1681.
Breast Cancer Res. 2007.
PMID: 17535433
Free PMC article.